跳至主要内容
临床试验/CTRI/2009/091/000914
CTRI/2009/091/000914招募中1 期

A Study of the Effect of Concomitant Administration of Rifampin on the Pharmacokinetics of BMS-708163 in Healthy Subjects

Bristol-Myers Squibb Research and Development311 Pennington-Rocky Hill RoadPennington, NJ 085340 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Signed Written Informed Consent
  • a) The signed informed consent form.
  • 2) Target Population
  • a) Healthy Indian subjects as determined by no clinically significant deviation from
  • normal in medical history, physical examination, ECGs, and clinical laboratory
  • determinations.
  • b) Body Mass Index (BMI) of 18 to 32 kg/m2, inclusive.
  • BMI = weight (kg)/ [height (m)]2.
  • 3) Age and Sex
  • a) Indian men and postmenopausal women (non-child bearing potential) ages
  • 18 to 55 years of age inclusive

排除标准

  • Sex and Reproductive Status
  • a) Women of child bearing potential (WOCBP):
  • WOCBP include any female who has experienced menarche and is not
  • postmenopausal.
  • Postmenopause is defined as:
  • ? Amenorrhea ≥12 consecutive months without another cause and a
  • documented serum FSH level >35 mIU/mL
  • ? Women with irregular menstrual periods and a documented serum FSH level
  • >35 mIU/mL
  • ? Women on HRT
  • Women who are using oral contraceptives, other hormonal contraceptives
  • (vaginal products, skin patches, or implanted or injectable products), or
  • mechanical products such as an intrauterine device or barrier methods
  • (diaphragm, condoms, spermicides) to prevent pregnancy, or are practicing
  • abstinence or where their partner is sterile (eg, vasectomy) should be considered
  • to be of childbearing potential.
  • b) Premenopausal women including surgically sterile women having undergone a
  • hysterectomy, bilateral tubal ligation, or bilateral oophorectomy
  • c) Women with a positive pregnancy test on enrollment or prior to administration of
  • investigational product.
  • d) Women who are pregnant or breastfeeding
  • e) Sexually active fertile men not using effective birth control (double barrier) if
  • their partners are WOCBP.
  • 2) Medical History and Concurrent Diseases
  • a) At risk for tuberculosis (TB) infection. Specifically subjects with:
  • i) Current clinical, radiographic or laboratory evidence of active or latent TB
  • ii) A history of active TB within the last 3 years, even if it was treated.
  • iii) A history of active TB greater than 3 years ago unless there is documentation
  • that the prior anti-TB treatment was appropriate in duration and type.

研究者

发起方
Bristol-Myers Squibb Research and Development311 Pennington-Rocky Hill RoadPennington, NJ 08534

相似试验